In This Issue
Health Policy in Action: A New Partnership to Advance Cardiometabolic Health
Upcoming Events: Advancing Whole-Person Health Care through North Carolina’s State Transformation Collaborative
People: Dev Sangvai
|
|
2024 Duke-Margolis Health Policy Conference
Our third annual Health Policy Conference brought together more than 500 leaders from across the country, virtually and in-person in Washington, DC, who represented a wide range of backgrounds and perspectives to address pressing health policy issues. This year’s theme, “Updating Health Care Reform for the Next Decade: Key Challenges and New Opportunities,” centered on finding a fresh, shared vision for health care innovation in 2025 and beyond.
The speakers emphasized key themes throughout the conference:
- Greater collaboration across sectors and political divides is needed to accomplish shared health care reform goals;
- More robust data collection and evidence development can help advance innovation, not only in clinical trials and medical technologies, but also in public health initiatives and more widespread adoption of value-based care; and
- A more holistic approach to care, one that considers the whole person and their community, can make a lasting impact on individual and population-level outcomes.
|
|
A New Partnership to Advance Cardiometabolic Health
Duke-Margolis, the Duke Clinical Research Institute, and Eli Lilly and Company are collaborating on a new initiative: the Platform for Evidence GeneraTion in Cardiometabolic HeaLth (PETAL). This project aims to identify barriers to implementing effective weight loss interventions and address health disparities in point-of-care clinical trial protocol. Read the press release here.
|
|
Guiding Opioid Settlement Fund Investment
|
|
Drug Price Negotiations
Assistant Research Director Nitzan Arad, Policy Research Assistant Grace Hoover, and Director Mark McClellan co-authored a Health Affairs Forefront article to offer recommendations to the Centers for Medicare & Medicaid Services (CMS) as they implement drug price negotiations under the Inflation Reduction Act. The authors’ guidance aims to advance the negotiation program’s predictability and reliability while minimizing the risk of unintended consequences.
BioCentury reported on this article and quoted Mark McClellan—read more here.
|
|
Optimizing Artificial Intelligence
Duke-Margolis researchers Christina Silcox, Katie Huber, Rob Saunders, and Mark McClellan co-authored an article in npj Digital Medicine that described four priority action areas recommended by international health leaders to fully realize the potential of artificial intelligence (AI) in health care: improving data quality to power AI, building infrastructure to encourage efficient and trustworthy development and evaluations, sharing data for better AI, and providing incentives to accelerate the progress and impact of AI.
|
|
Mental Health Services for Latino Youth
Former Duke-Margolis interns Francisco Banda and Karina Vasudeva, and Duke-Margolis researchers Greeshma James, Michelle Franklin, Andrea Thoumi, and Rushina Cholera, co-authored an article in the Journal of Racial and Ethnic Health Disparities to identify barriers and offer recommendations to address the Latino youth mental health crisis. A few specific recommendations included using destigmatized mental health language, incorporating promotoras and liaisons, respecting faith-based alternative care, and implementing group therapy. Read more here.
|
|
Social Determinants of Health Z-code Documentation
Research Director Rachele Hendricks-Sturrup and Sandra Yankah co-authored a review article in Health Affairs Scholar to describe the current International Classification of Diseases, Tenth Revision, Clinical Modification Z-code documentation practices for social determinants of health, with a focus on mental health care contexts. The authors offered policy and practice recommendations, along with considerations for patient data privacy, security, and confidentiality to incentivize more routine documentation of Z codes and better assist patients with complex mental health care needs. Read the full paper here.
|
|
Drug Shortages and Supply Chain
|
|
Advancing Whole-Person Care through North Carolina's State Transformation Collaborative
Location: Geneen Auditorium, Fuqua School of Business at Duke University, or virtual via Zoom
May 23, 2024 | 3 - 5pm ET
Learn more about the North Carolina State Transformation Collaborative’s activities since its launch in February 2023 and opportunities to continue advancing its key goals: improving population health, advancing health equity, enhancing patient experience, relieving provider burden, and reducing costs. In-person attendees also are welcome to attend a networking reception with light refreshments after the event.
|
|
Strengthening Whole-Person Specialty Care Through Accountable Care Innovation
Attendees learned more about the opportunities to strengthen high-value specialty care and develop new models for providers like orthopedists and cardiologists who manage patient care over longer periods of time than specialists primarily performing surgeries. Discussion centered on a recent Health Affairs Forefront post from the CMS Innovation Center that outlined the latest developments in their strategy to support person-centered, value-based specialty care.
Watch the event recording here.
|
|
Core Faculty member Dev Sangvai has been named President of Duke Regional Hospital. He has been the interim president since 2022 and has been working at Duke for 22 years. Congratulations on this new role, Dev! Read more here.
|
|
Research Director Christina Silcox spoke at the Alliance for Health Policy’s 2024 Signature Series thought leader convening, “AI in Health: Navigating New Frontiers,” to discuss the potential of artificial intelligence in health care as well as privacy and ethical concerns.
|
|
Duke University’s Fuqua School of Business presented an Excellence in Teaching Award to Core Faculty member David Ridley for his Weekend Executive elective course, Life Sciences Strategy. Congratulations, David!
|
|
Assistant Research Director Frank McStay presented Duke-Margolis’ work on opioid settlement funds at NatCon24, the conference for the National Council for Mental Health Wellbeing, during their session on “Data as a Catalyst for Smart Spending of Opioid Litigation Funds.”
|
|
Research Associate Samantha Repka also shared an overview of the opioid settlement funds work in a panel presentation, “Assessing Needs and Capacity: Using Data to Inform Sustainable Use of Opioid Settlement Funds,” at the 2024 Rx and Illicit Drugs Summit.
|
|
Assistant Research Director Stephen Colvill spoke at a plenary session during the National Comprehensive Cancer Network’s Annual Conference to discuss the impact of drug supply shortages on cancer care. Learn more about the conference here.
|
|
Opportunities at the Duke-Margolis Institute for Health Policy |
|
Do you want to be part of health policy in action? Do you want to work on the leading health policy issues confronting cities, states, the nation, and the globe? The Duke-Margolis team is a dynamic, high impact national leader in leveraging policy to ensure high quality, affordable care for all. Multiple positions are currently available with new ones added frequently. Click here to view all of our career opportunities.
|
|
|
|
|
|
|
